These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
329 related items for PubMed ID: 16802573
1. [Anderson-Fabry disease]. Kes P, Basić-Jukić N, Brunetta B, Jurić I. Acta Med Croatica; 2006; 60(1):55-8. PubMed ID: 16802573 [Abstract] [Full Text] [Related]
3. Clinical spectrum of Anderson Fabry disease in a Romanian family. Tudor A, Muşat A, Doscan A, Bari M, Zapucioiu C, Urdea E, Cochior D, Peţa D. Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300 [Abstract] [Full Text] [Related]
4. Renal involvement in Anderson-Fabry disease. Sessa A, Meroni M, Battini G, Righetti M, Maglio A, Tosoni A, Nebuloni M, Vago G, Giordano F. J Nephrol; 2003; 16(2):310-3. PubMed ID: 12774774 [Abstract] [Full Text] [Related]
5. Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa. Hughes DA, Elliott PM, Shah J, Zuckerman J, Coghlan G, Brookes J, Mehta AB. Heart; 2008 Feb; 94(2):153-8. PubMed ID: 17483124 [Abstract] [Full Text] [Related]
6. Anderson-Fabry disease: developments in diagnosis and treatment. Kes VB, Cesarik M, Zavoreo I, Madzar Z, Demarin V. Acta Clin Croat; 2012 Sep; 51(3):411-7. PubMed ID: 23330407 [Abstract] [Full Text] [Related]
11. [Peripheral neuropathy in Anderson-Fabry disease: its physiology, evaluation and treatment]. Politei JM, Pagano MA. Rev Neurol; 2009 Sep; 38(10):979-83. PubMed ID: 15175982 [Abstract] [Full Text] [Related]
12. In vitro study of encapsulation therapy for Fabry disease using genetically engineered CHO cell line. Naganawa Y, Ohsugi K, Kase R, Date I, Sakuraba H, Sakuragawa N. Cell Transplant; 2002 Sep; 11(4):325-9. PubMed ID: 12162373 [Abstract] [Full Text] [Related]
13. [Fabry disease]. Kantola I, Penttinen M, Nuutila P, Viikari J. Duodecim; 2012 Sep; 128(7):729-39. PubMed ID: 22612023 [Abstract] [Full Text] [Related]
14. An easy and sensitive method for determination of globotriaosylceramide (Gb3) from urinary sediment: utility for Fabry disease diagnosis and treatment monitoring. Rozenfeld PA, De Francesco NP, Borrajo GJ, Ceci R, Fossati CA. Clin Chim Acta; 2009 May; 403(1-2):194-7. PubMed ID: 19268437 [Abstract] [Full Text] [Related]
18. When should cardiologists suspect Anderson-Fabry disease? Gambarin FI, Disabella E, Narula J, Diegoli M, Grasso M, Serio A, Favalli BM, Agozzino M, Tavazzi L, Fraser AG, Arbustini E. Am J Cardiol; 2010 Nov 15; 106(10):1492-9. PubMed ID: 21059442 [Abstract] [Full Text] [Related]